**Author details**

Christian Caglevic1 \*, Mauricio Mahave2 , Cristobal Sanhueza<sup>3</sup> and Luis Ubillos4

1 Clinical Trials Unit, Cancer Research Department, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile

2 Medical Oncology Service, Instituto Oncologico Fundacion Arturo Lopez Perez, Santiago, Chile

3 Oncology Department, Facultad de Medicina, Clinica Alemana Santiago, Universidad del Desarrollo, Santiago, Chile

4 Medical Oncology, Hospital Britanico and Hospital de Clinicas UDELAR, Montevideo, Uruguay

\*Address all correspondence to: christian.caglevic@falp.org

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

*Current Systemic Treatment Options for Metastatic and Unresectable Pancreatic Cancer DOI: http://dx.doi.org/10.5772/intechopen.93225*
